riluzole has been researched along with Dysarthria, Pseudobulbar in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scott, K | 1 |
| Shannon, R | 1 |
| Roche-Green, A | 1 |
| Searcy, R | 1 |
| Woolyhand, G | 1 |
| Meeks, G | 1 |
| Schuh, M | 1 |
| Kraft, P | 1 |
| Beck, M | 1 |
| Grimm, A | 1 |
| Wessig, C | 1 |
| Reiners, K | 1 |
| Toyka, KV | 1 |
2 other studies available for riluzole and Dysarthria, Pseudobulbar
| Article | Year |
|---|---|
Pharmacologic Management Strategies in ALS #301.
Topics: Amyotrophic Lateral Sclerosis; Depression; Dyspnea; Guidelines as Topic; Humans; Muscle Spasticity; | 2016 |
[Amyotrophic lateral sclerosis: management of bulbar symptoms].
Topics: Affective Symptoms; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Combined Modality Therapy; | 2010 |